Company & Sponsor Intelligence

Arizona State University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting0

Completed7

Countries1

Therapeutic footprint

alzheimersautismdepressionstroke

Indexed studies

NCT04655326Probiotic Therapy for Children and Adults With Autism Spectrum Disorder
autism · United StatesNA

NCT03144921EPIC: An Intervention for Early-stage AD Dyads - Adapted for Virtual Delivery
alzheimers · United StatesNA

NCT04017793Mindfulness-Associated Brain Changes in Adults With Autism
autism · United StatesNA

NCT03313895The Combined Aerobic Exercise and Cognitive Training (ACT) Trial: The ACT Trial
alzheimers · United StatesNA

NCT02059577Nutritional and Dietary Treatment Study for Children/Adults With Autism
autism · United StatesPHASE2

NCT00051727Prevention of School Dropout for Mexican American Adolescents
depression · United StatesPHASE2

NCT05881096Effectiveness of START (Startle Adjuvant Rehabilitation Therapy) in Enhancing Arm Function Post-Stroke
stroke · United StatesEARLY_PHASE1

NCT04706806Effect of Daily Vinegar Ingestion for Four Weeks on Mood State in Healthy College Students
depression · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →